Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

Tuulia Hyötyläinen, Livnat Jerby, Elina M. Petäjä, Ismo Mattila, Sirkku Jäntti, Petri Auvinen, Amalia Gastaldelli, Hannele Yki-Järvinen, Eytan Ruppin (Corresponding Author), Matej Oresic (Corresponding Author)

Research output: Contribution to journalArticleScientificpeer-review

45 Citations (Scopus)

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a major risk factor leading to chronic liver disease and type 2 diabetes. Here we chart liver metabolic activity and functionality in NAFLD by integrating global transcriptomic data, from human liver biopsies, and metabolic flux data, measured across the human splanchnic vascular bed, within a genome-scale model of human metabolism. We show that an increased amount of liver fat induces mitochondrial metabolism, lipolysis, glyceroneogenesis and a switch from lactate to glycerol as substrate for gluconeogenesis, indicating an intricate balance of exacerbated opposite metabolic processes in glycemic regulation. These changes were associated with reduced metabolic adaptability on a network level in the sense that liver fat accumulation puts increasing demands on the liver to adaptively regulate metabolic responses to maintain basic liver functions. We propose that failure to meet excessive metabolic challenges coupled with reduced metabolic adaptability may lead to a vicious pathogenic cycle leading to the co-morbidities of NAFLD.
Original languageEnglish
Article number8994
JournalNature Communications
Volume7
DOIs
Publication statusPublished - 2016
MoE publication typeA1 Journal article-refereed

Fingerprint

genome
liver
Liver
Genes
Genome
Fats
fats
metabolism
Gluconeogenesis
Viscera
Metabolism
Lipolysis
Glycerol
Type 2 Diabetes Mellitus
Blood Vessels
Non-alcoholic Fatty Liver Disease
Liver Diseases
Lactic Acid
Chronic Disease
lactates

Keywords

  • Medical research
  • Metabolism
  • non-alcoholic fatty liver disease
  • Transcriptomics

Cite this

Hyötyläinen, T., Jerby, L., Petäjä, E. M., Mattila, I., Jäntti, S., Auvinen, P., ... Oresic, M. (2016). Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease. Nature Communications, 7, [8994]. https://doi.org/10.1038/ncomms9994
Hyötyläinen, Tuulia ; Jerby, Livnat ; Petäjä, Elina M. ; Mattila, Ismo ; Jäntti, Sirkku ; Auvinen, Petri ; Gastaldelli, Amalia ; Yki-Järvinen, Hannele ; Ruppin, Eytan ; Oresic, Matej. / Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease. In: Nature Communications. 2016 ; Vol. 7.
@article{b2654b701f4b4eea9855e824cf318f58,
title = "Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease",
abstract = "Non-alcoholic fatty liver disease (NAFLD) is a major risk factor leading to chronic liver disease and type 2 diabetes. Here we chart liver metabolic activity and functionality in NAFLD by integrating global transcriptomic data, from human liver biopsies, and metabolic flux data, measured across the human splanchnic vascular bed, within a genome-scale model of human metabolism. We show that an increased amount of liver fat induces mitochondrial metabolism, lipolysis, glyceroneogenesis and a switch from lactate to glycerol as substrate for gluconeogenesis, indicating an intricate balance of exacerbated opposite metabolic processes in glycemic regulation. These changes were associated with reduced metabolic adaptability on a network level in the sense that liver fat accumulation puts increasing demands on the liver to adaptively regulate metabolic responses to maintain basic liver functions. We propose that failure to meet excessive metabolic challenges coupled with reduced metabolic adaptability may lead to a vicious pathogenic cycle leading to the co-morbidities of NAFLD.",
keywords = "Medical research, Metabolism, non-alcoholic fatty liver disease, Transcriptomics",
author = "Tuulia Hy{\"o}tyl{\"a}inen and Livnat Jerby and Pet{\"a}j{\"a}, {Elina M.} and Ismo Mattila and Sirkku J{\"a}ntti and Petri Auvinen and Amalia Gastaldelli and Hannele Yki-J{\"a}rvinen and Eytan Ruppin and Matej Oresic",
year = "2016",
doi = "10.1038/ncomms9994",
language = "English",
volume = "7",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

Hyötyläinen, T, Jerby, L, Petäjä, EM, Mattila, I, Jäntti, S, Auvinen, P, Gastaldelli, A, Yki-Järvinen, H, Ruppin, E & Oresic, M 2016, 'Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease', Nature Communications, vol. 7, 8994. https://doi.org/10.1038/ncomms9994

Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease. / Hyötyläinen, Tuulia; Jerby, Livnat; Petäjä, Elina M.; Mattila, Ismo; Jäntti, Sirkku; Auvinen, Petri; Gastaldelli, Amalia; Yki-Järvinen, Hannele; Ruppin, Eytan (Corresponding Author); Oresic, Matej (Corresponding Author).

In: Nature Communications, Vol. 7, 8994, 2016.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

AU - Hyötyläinen, Tuulia

AU - Jerby, Livnat

AU - Petäjä, Elina M.

AU - Mattila, Ismo

AU - Jäntti, Sirkku

AU - Auvinen, Petri

AU - Gastaldelli, Amalia

AU - Yki-Järvinen, Hannele

AU - Ruppin, Eytan

AU - Oresic, Matej

PY - 2016

Y1 - 2016

N2 - Non-alcoholic fatty liver disease (NAFLD) is a major risk factor leading to chronic liver disease and type 2 diabetes. Here we chart liver metabolic activity and functionality in NAFLD by integrating global transcriptomic data, from human liver biopsies, and metabolic flux data, measured across the human splanchnic vascular bed, within a genome-scale model of human metabolism. We show that an increased amount of liver fat induces mitochondrial metabolism, lipolysis, glyceroneogenesis and a switch from lactate to glycerol as substrate for gluconeogenesis, indicating an intricate balance of exacerbated opposite metabolic processes in glycemic regulation. These changes were associated with reduced metabolic adaptability on a network level in the sense that liver fat accumulation puts increasing demands on the liver to adaptively regulate metabolic responses to maintain basic liver functions. We propose that failure to meet excessive metabolic challenges coupled with reduced metabolic adaptability may lead to a vicious pathogenic cycle leading to the co-morbidities of NAFLD.

AB - Non-alcoholic fatty liver disease (NAFLD) is a major risk factor leading to chronic liver disease and type 2 diabetes. Here we chart liver metabolic activity and functionality in NAFLD by integrating global transcriptomic data, from human liver biopsies, and metabolic flux data, measured across the human splanchnic vascular bed, within a genome-scale model of human metabolism. We show that an increased amount of liver fat induces mitochondrial metabolism, lipolysis, glyceroneogenesis and a switch from lactate to glycerol as substrate for gluconeogenesis, indicating an intricate balance of exacerbated opposite metabolic processes in glycemic regulation. These changes were associated with reduced metabolic adaptability on a network level in the sense that liver fat accumulation puts increasing demands on the liver to adaptively regulate metabolic responses to maintain basic liver functions. We propose that failure to meet excessive metabolic challenges coupled with reduced metabolic adaptability may lead to a vicious pathogenic cycle leading to the co-morbidities of NAFLD.

KW - Medical research

KW - Metabolism

KW - non-alcoholic fatty liver disease

KW - Transcriptomics

U2 - 10.1038/ncomms9994

DO - 10.1038/ncomms9994

M3 - Article

VL - 7

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 8994

ER -